Immunotherapy Toxicity (irAE)
Immunotherapy Toxicity (irAE)
Immune-related adverse events (irAEs) from checkpoint inhibitors (PD-1, PD-L1, CTLA-4) affect any organ. Most common: dermatitis, colitis, pneumonitis, hepatitis, endocrinopathies. Steroids are primary treatment.
Latest evidence
What this condition is
What is prostate cancer?Cancer is a disease in which cells in the body grow out of control. Prostate cancer begins in the cells of the prostate. The prostate is a gland in the male reproductive system. It lies just below the bladder. It makes fluid that is part of semen.Prostate cancer is one of the most common types of cancer. It often grows very slowly. If it does not spread to other parts of the body, it may not…
Open official source →Tests performed
Recognize the drug and the class
NANDA diagnoses & care plans
Use these direct links to open nursing diagnoses and care-plan support related to Immunotherapy Toxicity (irAE).
Plain-language study support
Useful for plain-language reinforcement and quick review.